MedPath

DelArrivo, Inc.

Ownership
Private
Employees
-
Market Cap
-
Website

A Study of DLX105-DMP in Subjects With Plaque Psoriasis

Phase 1
Completed
Conditions
Plaque Psoriasis
Interventions
First Posted Date
2019-12-18
Last Posted Date
2023-05-03
Lead Sponsor
DelArrivo, Inc.
Target Recruit Count
10
Registration Number
NCT04203433
Locations
🇺🇸

DelArrivo Investigational Site, Norfolk, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath